Evaluation of musculoskeletal phenotype of the G608G progeria mouse model with lonafarnib, pravastatin, and zoledronic acid as treatment groups

Cubria, Maria B, Sebastian Suarez, Aidin Masoudi, Ramin Oftadeh, Pramod Kamalapathy, Amanda J Dubose, Michael R Erdos, et al. 2020. “Evaluation of Musculoskeletal Phenotype of the G608G Progeria Mouse Model With Lonafarnib, Pravastatin, and Zoledronic Acid As Treatment Groups”. Proceedings of the National Academy of Sciences 117 (22).
Last updated on 03/07/2025